BCL2 and melanoma: Phosphorylated STAT5 is regulated by rEGF in melanoma, and inhibition of STAT5B expression can significantly reduce the expression of BCL-2, resulting in decreased cell survival rate and increased apoptosis (Mirmohammadsadegh et al., 2006).